Germany
· Delayed Price · Currency is EUR Dr. Hönle AG Statistics
Total Valuation
Dr. Hönle AG has a market cap or net worth of EUR 60.92 million. The enterprise value is 108.07 million.
| Market Cap | 60.92M |
| Enterprise Value | 108.07M |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 6.06M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 37.49 |
| PS Ratio | 0.62 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.92 |
| P/FCF Ratio | 33.06 |
| P/OCF Ratio | 14.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.06, with an EV/FCF ratio of 58.64.
| EV / Earnings | -8.34 |
| EV / Sales | 1.10 |
| EV / EBITDA | 19.06 |
| EV / EBIT | n/a |
| EV / FCF | 58.64 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.66.
| Current Ratio | 1.86 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 9.25 |
| Debt / FCF | 28.50 |
| Interest Coverage | 0.14 |
Financial Efficiency
Return on equity (ROE) is -14.69% and return on invested capital (ROIC) is 0.13%.
| Return on Equity (ROE) | -14.69% |
| Return on Assets (ROA) | 0.11% |
| Return on Invested Capital (ROIC) | 0.13% |
| Return on Capital Employed (ROCE) | 0.24% |
| Revenue Per Employee | 181,122 |
| Profits Per Employee | -23,985 |
| Employee Count | 590 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.15 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.37% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -49.37% |
| 50-Day Moving Average | 9.24 |
| 200-Day Moving Average | 9.98 |
| Relative Strength Index (RSI) | 54.32 |
| Average Volume (20 Days) | 10,685 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Hönle AG had revenue of EUR 97.81 million and -12.95 million in losses. Loss per share was -2.14.
| Revenue | 97.81M |
| Gross Profit | 60.24M |
| Operating Income | 287,000 |
| Pretax Income | -11.82M |
| Net Income | -12.95M |
| EBITDA | 4.67M |
| EBIT | 287,000 |
| Loss Per Share | -2.14 |
Balance Sheet
The company has 5.51 million in cash and 52.52 million in debt, giving a net cash position of -47.02 million.
| Cash & Cash Equivalents | 5.51M |
| Total Debt | 52.52M |
| Net Cash | -47.02M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 79.42M |
| Book Value Per Share | 13.08 |
| Working Capital | 26.41M |
Cash Flow
In the last 12 months, operating cash flow was 4.24 million and capital expenditures -2.40 million, giving a free cash flow of 1.84 million.
| Operating Cash Flow | 4.24M |
| Capital Expenditures | -2.40M |
| Free Cash Flow | 1.84M |
| FCF Per Share | n/a |
Margins
Gross margin is 61.59%, with operating and profit margins of 0.29% and -13.24%.
| Gross Margin | 61.59% |
| Operating Margin | 0.29% |
| Pretax Margin | -12.09% |
| Profit Margin | -13.24% |
| EBITDA Margin | 4.77% |
| EBIT Margin | 0.29% |
| FCF Margin | 1.88% |
Dividends & Yields
Dr. Hönle AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -21.26% |
| FCF Yield | 3.03% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dr. Hönle AG has an Altman Z-Score of 1.78. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.78 |
| Piotroski F-Score | n/a |